ClinicalTrials.gg
TerminatedNCT04572646PATCHIRUpdated Feb 16, 2023

Benefit of Systematic Proposition of Nicotine Substitution for Patients Undergoing Surgery

An interventional study of NRT proposition and exhaled CO measurement in Smoking Cessation, sponsored by Groupe Hospitalier Mutualiste de Grenoble. Terminated at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-02-16.

Sponsored by Groupe Hospitalier Mutualiste de Grenoble · Not applicable, Interventional, and Prevention

How we know

Why this study was terminated
Recruitment goal not feasible

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 48 studies in Smoking Cessation with a site in France — 8 open to participants now, 11 under way, 1 of them phase 3. Smoking Cessation · France.

Enrollment
39th of 43
20 · median 124
Started
2020
with 2 others
No phase
21 of 48
7 open now
Registered
27th of 48
by date
Lead sponsor
2 of 48
Groupe Hospitalier Mutualiste de Grenoble

Among the 48 studies in Smoking Cessation with a site in France, this one is the 39th largest by enrollment of the 43 interventional ones that give a count, is one of 3 that started in 2020, is one of 21 with no phase, and was the 27th registered.

Smoking Cessation

1,583 studies on the registry are indexed under Smoking Cessation; 196 are open to participants now.

Browse Smoking Cessation studies →

Open to participants now

8 of the 48 studies in Smoking Cessation with a site in France are open now. Recruiting first, the newest first:

3 more — sign in →

All 8 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 134 Smoking Cessation studies recruiting now, 92 (69%) set no upper age limit and 35 (26%) stop at 75 or younger; 6 take children under 18; 40 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 48 studies in Smoking Cessation with a site in France, or all of them as a file.
02

Study summary

Smoking is associated with a higher rate of surgical complications. For example, in orthopedics, the risk of complications is 31% in smokers against 5% in non-smokers. The management of this addiction is recommended and particularly interesting in scheduled surgery, because it allows smoking cessation well before the procedure. However, for patients who cannot consider this smoking cessation, the mere information of the risk cannot be sufficient and a real strategy must be constructed and evaluated.

Currently, studies results indicate that a patient reducing the number of smoked cigarettes will unconsciously modify their smoking behaviour to obtain the usual nicotine level, this effect is called self-titration. Conversely, nicotine replacement while continuing consumption could induce an improvement in smoking behaviour, therefore less intoxication which would be beneficial in terms of reduction of post-operative complications. This study seeks to assess the effectiveness of a systematic proposition of nicotine replacement therapy (NRT) in regular smokers. Tobacco addiction specialists have demonstrated that intoxication and dependence are well correlated with the exhaled carbon monoxide (CO) level, so this measurement will be used in addition to the patient's interview.

03

Conditions studied

  • Smoking Cessation

Keywords

  • postoperative complication
  • nicotine replacement therapy
  • exhaled carbon monoxide level
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient who smokes at least one cigarette or cannabis joint per day, every day
  • Patient received for nurse consultation at least 48 hours before surgery
  • Patient planned to undergo surgery, with entry the day of surgery and 1 day of post-operative hospitalisation
  • Patient in physical capacity and willing to undergo exhaled carbon monoxide measurement
  • For patients with one of the following chronic diseases: diabetes, , glucose intolerance, hemolytic anemia, asthma and dilation of the bronchi, these diseases must be stable
  • Signature of the specific study
  • Patient affiliated or beneficiary of social security system

Exclusion criteria

Exclusion Criteria:

  • Inability to submit to study follow-up for geographic, social or psychological reasons
  • Patient already included in an interventional clinical research protocol
  • Patients protected by French law from clinical research inclusion (pregnant, in labour, breastfeeding, legally protected, under judiciary or administrative liberty deprivation)
  • Patient using nicotine substitutes before the nurse consultation
  • Alcohol consumption six hours before the exhaled carbon monoxide measurement
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (actual)

Study arms

  • Other
    NRT proposition and exhaled CO measurement

    Other: NRT proposition and exhaled CO measurement

Interventions

  • OtherNRT proposition and exhaled CO measurement

    Nicotine replacement therapy is proposed to every patient included in the study. Whether the patient accepts the therapy or not, exhaled carbon monoxide is measured at the preoperative consultation (about 15 days before surgery) and the day of surgery by a nurse. These two measures are compared to assess efficacy of nicotine replacement therapy.

06

What researchers measure

Primary outcomes

  1. Efficacy of a systematic proposition of nicotine replacement therapy, regardless of the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitor

    Time frame: At inclusion, and before surgery

Secondary outcomes

  1. Number of patients who refuse nicotine replacement therapy

    Time frame: At inclusion

  2. Effect of nicotine replacement therapy on the type of analgesics administrated

    Time frame: At inclusion, before surgery, and 2 days after surgery

  3. Effect of nicotine replacement therapy on the duration of analgesics administrated

    Time frame: At inclusion, before surgery, and 2 days after surgery

  4. Effect of nicotine replacement therapy on the dose of analgesics administrated

    Time frame: At inclusion, before surgery, and 2 days after surgery

  5. Number of smoking cessations

    Time frame: 2 days after surgery

  6. Efficacy of a systematic proposition of nicotine replacement therapy, depending on the intention to quit Change in exhaled carbon monoxide level between the two measurements, assessed by a carbon monoxide breath monitor

    Subgroup analysis of the primary endpoint according to predefined groups

    Time frame: At inclusion, and before surgery

07

Study locations

1 site
  • Groupe hospitalier Mutualiste de Grenoble
    Grenoble, 38028, France
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Aug 2020 to primary completion in May 2022, 21 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 15, 2020
First posted
Oct 1, 2020
StartActual
Aug 24, 2020
Primary completionActual
May 31, 2022
CompletionActual
May 31, 2022
Last update
Feb 16, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04572646
Lead sponsor
Groupe Hospitalier Mutualiste de Grenoble
Responsible party
Sponsor
First posted
Oct 1, 2020
Start date
Aug 24, 2020
Primary completion
May 31, 2022
Completion
May 31, 2022
Last update
Feb 16, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Mar 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion